ByteDance, the parent company of TikTok, is expanding into artificial intelligence-driven drug discovery through its unit, Anew Labs. This unit has begun presenting its AI-designed therapies at international conferences, showcasing advancements in biotech innovation. Operating from Shanghai, Singapore, and San Jose, California, Anew Labs highlights ByteDance's increasing investment in cutting-edge AI applications beyond social media.